Jens Kollmeier

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · The Lancet Oncology · 2019 · 594 citations · Full text

Medicine, Pathology, Immune Checkpoint Inhibitor +5

Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer

Daniel G. Weber, Georg Johnen, Swaantje Casjens et al. · BMC Research Notes · 2013 · 187 citations · Full text

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study

Christian Boch, Jens Kollmeier, Andreas Röth et al. · BMJ Open · 2013 · 147 citations · Full text

Morphometrical analysis of transbronchial cryobiopsies

Sergej Griff, Wim Ammenwerth, Nicolas Schönfeld et al. · Diagnostic Pathology · 2011 · 131 citations · Full text

Interventional Pulmonology, Peripheral Lung Tissue, Advanced Lung Disease +24

Metastasectomy for Synchronous Solitary Non-Small Cell Lung Cancer Metastases

Mario Tönnies, Joachim Pfannschmidt, Torsten T. Bauer et al. · The Annals of Thoracic Surgery · 2014 · 88 citations

Surgical Oncology, Medicine, Surgical Pathology +4